Call For Abstract

Scientific Program

4^thInternational Conference on Gynecology & Obstetrics, will be organized around the theme “Best Practice & Research in Obstetrics & Gynecology”

Gynecology 2017 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Gynecology 2017

Submit your abstract to any of the mentioned tracks.

Track 1:Gynecology & Obstetrics

Track 1-1Contraception
Track 1-2Principles and Practice of Oncology in Gynecology
Track 1-3Anatomy in Females of Genitourinary System, Abdomen, Pelvis , Pelvic Floor , Anterior Abdominal Wall and Breast.
Track 1-4Operative Gynecology
Track 1-5 Placenta - Development, Structure, Functions
Track 1-6Endocrinology of Pregnancy
Track 1-7Normal Pregnancy, Labour & Puerperium
Track 1-8Recent Advances in Medical and Surgical Management
Track 1-9Infections in Pregnancy
Track 1-10Obstetrical Analgesia and Anesthesia
Track 1-11Operative Obstetrics
Track 1-12Basics of Breast Diseases related to OB/GY
Track 1-13Physiology of Menstruation and Ovulation
Track 1-14Recent Advances in Gynecology
Track 1-15Pregnancy Care and Delivery
Track 1-16Lactation Support

Track 2:Midwifery

Track 1. Midwifery :

Midwifery is an eclectic field and is professional in gynecology and Number of Research institutes working on the Midwifery are approximately 20 or more as well as some universities are giving training to women to be midwifery and most of midwives are women, total number of universities are approximately 60 which are working on midwives and the funding is around $10000- $20000 and Academia 40% , 30% industry and Others 30% are included in this topic. Midwife is a profession in obstetrics as well. The term midwife is used in reference to both women and men, although most midwives are women. In Many International Gynecology Conferences and Gynecology Meetings around the world has included the advancements of Midwifery and has proved to be an essential topic As per the definition of the International Confederation of Midwives, which has been adopted by the WHO and the International Federation of Gynecology and Obstetrics: A Midwife is a person who is regularly admitted to a midwifery educational program that is suitably recognized in the country in which it is located, and who has successfully completed the stipulated course of studies in midwifery and has obtained the essential qualifications to be registered and legally licensed to practice midwifery. Midwifery in the low income countries like Egypt, Pakistan, India, Uzbekistan, Baluchistan , Ethiopia and some of the regions of south America and other countries.

19th World Cancer Conference, November 21-23, 2017 London, UK; Annual Scientific Meeting of the British Gynaecological Cancer Society, 15-16 June 2017 Glasgow, UK; 8th Blood Cancer Conference June 26-27, 2017 London, UK; 3^rd Urologic Oncology Conference June 26-28, 2017 Baltimore; 2^nd Cancer Diagnostics Conference May 8-10, 2017 Barcelona, Spain; 16^th Global Annual Oncologists Meeting April 24-25, 2017 Dubai, UAE; Yokohama, Japan; European Lung Cancer Conference, May 5-8,2017,Switzerland;Gastrointestinal Cancer Conference, October 16-18, 2017 Baltimore, USA

Track 2-1Midwifery Care
Track 2-2Midwifery in Low Income Countries
Track 2-3Recent Developments in Midwifery Research
Track 2-4Midwifery in Multi-Ethnic Community

Track 3:Maternal Fetal Medicine

Track 2. Maternal-Fetal Medicine

Maternal-fetal medicine is a vast topic and is professional in gynecology and the Nymber of Research institutes working on the Maternal-fetal medicine are approximately 33 or more and as well as some universities which are giving training to women to be Professionals in Maternal-fetal medicine , total number of universities offering this promising topic are approximately 160 working on Maternal-fetal medicine and there is also a funding of around $30000- $50000 and Academia 30% , 20% industry and Others 50% are included in this topic. As discussed in many gynecologic conferences and gynecologic meetings worldwide, Maternal-fetal medicine is a branch of obstetrics which emphasize on medical and surgical management of high-risk pregnancy cases. Management include monitoring and treatment and comprehensive ultrasound, chorionic villus sampling , genetic amniocentesis and fetal surgery/treatment. Obstetricians who are practicing maternal-fetal medicine are also called as primatologists. This is a sub-specialty of obstetrics and gynaecology which is mainly used for patients with high risk pregnancies. Obstetric medicine is a meticulously related specialty that focuses on the care of medical problems in pregnancy.

24th Global Nursing & Healthcare Conference March 01-02, 2017 , Amsterdam, Netherlands; 3rd Annual Congress and Medicare Expo on Trauma & Critical Care, March 13-14, 2017 , London, UK; 3rd Annual Congress & Medicare Expo on Primary Healthcare ;April 17-19, 2017 ,Dubai, UAE; 6th International Conference and Exhibition on Occupational Health & Safety April 18-19, 2017 ,London, UK; 19th Global Nursing Education Conference April 27-28, 2017 , Las Vegas, USA;4th World Congress on Breast Cancer and Women’s Health ,May 08-10, 2017 , Singapore City, Singapore; 20th World Nursing Education Conference,
May 22-24, 2017 , Osaka, Japan; 29th World Congress on Community Nursing and Public Health,
May 22-23, 2017 , Chicago, USA;5th World Congress on Breast Cancer ,June 15-17, 2017 , London, UK; 2nd International Conferences on Reproductive Health and Medicine ,June 26-27, 2017 , London, UK.

Track 3-1Pre-Pregnancy Underweight and Fetal Growth
Track 3-2Pregnancy Termination Practice
Track 3-3Signalling, Status and Inequities in Maternal Healthcare
Track 3-4Body Mass Index (BMI) Guidelines for Fertility Treatmen
Track 3-5Maternal Fetal Medicine Practice & Procedures
Track 3-6Fetal Blood Sampling

Track 4:Uro- Gynecology

Track 3. Urogynecology

Uro gynecology is an extensive topic and is professional in gynecology and the number of Research institutes working on the Uro gynecology are approximately 30 or more and some universities also give training to women on Uro gynecology , total number of universities which focus on this area are approximately 70 and also obtain a funding of around $10000- $30000 and includes 10% industry, 30% of academia and Others 60% .It is a surgical sub-specialty of urology and gynecology. Urogynecology is also a subspecialty of Female Pelvic Medicine and Reconstructive Surgery. Uro gynecology involves diagnosis and treatment of urinary incontinence and female pelvic floor disorders. Robotic-assisted surgery has evolved vastly over the past two decades with persistantly improving technology, proving to assist surgeons in multiple subspecialty disciplines as discussed in many gynecologic conferences and gynecologic meetings worldwide.

3rd International Conference on Reproductive Health ,October 05-06, 2017 , Chicago, USA; 3rd World Congress on Polycystic Ovarian Syndrome ,November 15-17, 2017 , San Antonio, USA; Global Summit on Oncology & Cancer,May 25-27, 2017 ,Osaka, Japan; International Conference on Cancer Biology R&D and Market, June 21 - 22, 2017 , Philadelphia, USA; 8th International Conference on Blood and Oncology Research,June 26-28, 2017 , London, UK; International Conference on Hematology and Oncology;
June 29-July 01, 2017 , Bangkok, Thailand;19th Euro Congress on Cancer Science and Therapy ,
July 17-19, 2017 , Lisbon, Portugal; 3rd Annual Conference on Gynecologic Oncology ,
July 20-21, 2017 , Chicago, USA

Track 4-1Gynecologic and Urology Surgery
Track 4-2Complications in Endoscopic Surgery
Track 4-3Management of the Ureter During Pelvic Surgery
Track 4-4Urinary Incontinence and Interstitial Cystitis
Track 4-5Vaginal Agenesis and Vesicovaginal Fistulas

Track 5:Gynecological Endocrinology

Track 4. Gynecological Endocrinology

There are a large Number of Research institutes working on the Gynecological Endocrinology which are approximately 25 and the Number of Universities working on this topic are approximately 80 and funding for the research given by University or a research institute is around $20000 - $30000 including Academia 20% , 30% industry and Others 50%. Gynecological Endocrinology focuses on the treatment of disorders related to menstruation, fertility and menopause. Reproductive endocrinology and Fetal-Placental neuroendocrine development refers to a subspecialty that focuses on the biological causes and its interventional treatment of infertility and its development.

13th World Congress on Diabetes October 05-06, 2017 London ,UK; 12th International Conference on Endocrinology and Diabetes Summit November 06-07, 2017 Singapore;20th World Summit on Diabetes, Nutrition, Metabolism & Medicare July 24-26,2017 Vancouver, Canada; 18th European Diabetes Congress July 17-18, 2017 Lisbon, Portugal; 10th Diabetologists Conference July 24-26,2017 Vancouver, Canada; 19th Asia Pacific Diabetes Conference July 20-22, 2017 Melbourne, Australia;7th European Diabetes and Endocrinology Congress May 18-19,2017 Munich, Germany ; 16th Global Diabetes Conference & Medicare Expo March 22-23, 2017 Rome, Italy; 8th International Conference on Adrenal & Thyroid Disorders, Treatment June 12-13, 2017 Taiwan, Taipei.

Track 5-1Fetal-Placental Neuroendocrine Development
Track 5-2Paediatric and Adolescent Gynecology
Track 5-3Pregnancy and Diabetes
Track 5-4Neuroendocrinology of Reproduction
Track 5-5Reproductive Endocrinology

Track 6:Gynecological Oncology

Track 5. Gynecological Oncology

As discussed in many Gynecologic conferences and Gynecologic meetings worldwide, it is stated that around 80,000 women are diagnosed with gynecologic cancers in the USA, and half of those were uterine cancer diagnoses with deaths of 8,000 women per year. Ovarian cancer is found to be the 2nd most common gynecologic cancer with around 22,000 new cases every year, leading to 16,000 deaths per year. Mortality of cases in cervical cancer have been decreased as Pap smears have become common in place. however there are about 12,000 diagnoses every year in which about 4,200 women die from this disease every year. Vulvar and vaginal cancer are comparitively rare and when diagnosed and treated early it offers good prognosis. 4,500 women are being diagnosed with vulvar cancer each year, in which there is about 950 deaths among them. Vaginal cancer account for about 2,600 diagnoses each year causing about 840 deaths. Every woman is at risk for augmenting a gynecologic cancer. It is estimated that there will be aroung 98,000 new cases diagnosed and approximately causing 30,000 deaths from gynecologic cancers in the USA during the year 2015 stated as per The American Cancer Society, in which Uterine cancer may have the large portion of about 50% cases with an estimated mortality rate of approximately 18.5%. The Ovarian cancer has the highest estimated mortality rate at 66%.

Gynecologic Oncology Congress, July 20-21, 2017 Chicago, USA; 18^th World Conference on Lung Cancer October 15 - 18 2017; Preventive oncology July 20-21, 2017 Chicago, USA; 9^th Cancer Biomarkers Conference August 23-24, 2017 Birmingham, UK; 19th World Cancer Conference, November 21-23, 2017 London, UK; Annual Scientific Meeting of the British Gynaecological Cancer Society, 15-16 June 2017 Glasgow, UK; 8th Blood Cancer Conference June 26-27, 2017 London, UK; 3^rd Urologic Oncology Conference June 26-28, 2017 Baltimore; 2^nd Cancer Diagnostics Conference May 8-10, 2017 Barcelona, Spain; 16^th Global Annual Oncologists Meeting April 24-25, 2017 Dubai, UAE; Yokohama, Japan; European Lung Cancer Conference, May 5-8,2017,Switzerland;Gastrointestinal Cancer Conference, October 16-18, 2017 Baltimore, USA; Breast Cancer Conference, October 16-18, 2017 San Francisco, USA; ESMO 2017 Congress, September 8-12, 2017, Spain;

Track 6-1Radiation Therapy for Gynecologic Cancers
Track 6-2Palliative Care in Gynecological Oncology
Track 6-3Oncology Scan – Gynecological Cancers
Track 6-4Ovarian and Cervical Oncology
Track 6-5Fibroids and Breast Oncology

Track 7:Reproductive Medicine

Track 6. Reproductive Medicine

Reproductive Medicine in Gynecology is ever growing area. The number of Research institutes which are working on reproductive medicine are approximately 120 and the number of Universities are around 20-30 which have the department of Medicine and the funding towards this research is over $90000 - $110000, Target audience are of Academia 20%, 50% industry and 30% of others. Reproductive medicine is a branch of medicine which focuses on prevention, diagnosis and management of the reproductive problems. The goals include improving or maintaining reproductive health and allowing people to have children at a time of their choice as discussed in many gynecologic conferences and gynecologic meetings worldwide. It is focused on knowledge of reproductive anatomy, physiology and endocrinology which also incorporates relevant aspects of molecular biology, biochemistry and pathology. Regenerative medicine emphasizes on process of replacing, engineering or regenerating human cells, tissues or organs to restore/establish normal function.

16th Global Annual Oncologists Meeting ,April 24-25, 2017 , Dubai, UAE; 2nd Cancer Diagnostics Conference & Expo ,May 8-10, 2017 , Barcelona, Spain;Global Summit on Oncology & Cancer,May 25-27, 2017 ,Osaka, Japan; International Conference on Cancer Biology R&D and Market, June 21 - 22, 2017 , Philadelphia, USA; 8th International Conference on Blood and Oncology Research
June 26-28, 2017 , London, UK; International Conference on Hematology and Oncology;
June 29-July 01, 2017 , Bangkok, Thailand;19th Euro Congress on Cancer Science and Therapy ,
July 17-19, 2017 , Lisbon, Portugal; 3rd Annual Conference on Gynecologic Oncology ,
July 20-21, 2017 , Chicago, USA; World Congress on Preventive Oncology,July 20-21, 2017 ,Chicago, USA; 9th International Conference on Biomarkers,August 07-09, 2017 , Osaka, Japan.

Track 7-1Neuroendocrinology of Reproduction
Track 7-2Regenerative Medicine and Their Application
Track 7-3Personalized Reproductive Medicine
Track 7-4Biomarkers in Reproductive Medicine
Track 7-5Reproductive Cloning
Track 7-6Hysteroscopy Prior to Assisted Reproductive Technique
Track 7-7Biomarkers in Reproductive Medicine
Track 7-8Reproductive Endocrinology

Track 8:Prenatal Diagnosis

Track 7. Prenatal Diagnosis

Prenatal Diagnosis is included in the vast area of Gynecology. The number of Research institutes which are working on Prenatal Diagnosis are approximately 20-30 approximately and the number of Universities are around 80 which have the department of Gynecology and the funding towards this research is over $10000 - $20000 , Target audience are of 40% industry, Academia 20% and 40% of others. Prenatal Dignosis is stated as the testing for diseases or conditions in a fetus or embryo before the child is born. Diagnostic prenatal testingcan be performed by many invasive or non-invasive methods. As discussed in many gynecologic conferences and gynecologic meetings worldwide, the aim of this is to detect birth defects such as neural tube defects, Down syndrome, genetic disorders, chromosome abnormalities and other conditions such as sickle cell anemia , spina bifida, Tay Sachs disease, cystic fibrosis, Muscular dystrophy, cleft palate, thalassemia, and fragile X syndrome. Non-invasive techniques includes examinations of the woman's womb by using ultrasonography and maternal serum screens.

Track 8-1Prenatal Diagnosis Process
Track 8-2Advanced Techniques for Prenatal Diagnosis
Track 8-3Prenatal Diagnosis, Molecular Genetic Analysis
Track 8-4Prenatal Diagnosis Using Three-Dimensional Ultrasound
Track 8-5Advanced Techniques for Prenatal Diagnosis
Track 8-6Detection and Prevention of Cogenital Anomalies

Track 9:Family Planning

Track 8: Family Planning

The critical step in the management of world population includes Contraception and Family planning measures. The world is distinguishing a huge vault over in the development of recent contraceptive technologies and assisted reproductive technologies such as achieving pregnancy in procedures like in vitro fertilization , artificial insemination and surrogacy to fight issues like infertility and its assessment. As discussed in many gynecologic conferences and gynecologic meetings worldwide , High-risk patients include patients with diseases like hypertension, Sexually transmitted diseases, diabetes and other complications and the advancing trends in contraception and technologies will render a crucial role in regulating a large number of Reproductive Health indicators.

International Conference on Reproductive Health, December 04-06, 2017, Chicago, USA, 3rd World Congress on Polycystic Ovarian Syndrome, November 09-11, 2017 San Antonio, USA, 2nd World Congress on Midwifery and Women’s Health, Aug 28-30, 2017 Philadelphia, USA, Europe Midwifery and Women’s Health 2017 October 2-4, 2017 London, UK, 7^th Global Nursing and Healthcare Conference August 18-20, 2016, Brazil, 6th World Nursing and Healthcare Conference August 15-17, 2016, UK. 8^th Nursing and Healthcare Congress October 3-5, 2016, Canada.

Track 9-1Family Planning - Evaluation of Weight and Blood Pressure
Track 9-2Advanced Methods in Family Planning
Track 9-3Teenage Pregnancy
Track 9-4Post-Abortion Family Planning
Track 9-5Pelvic Floor Dysfunction
Track 9-6Age at Menopause
Track 9-7Contraceptive vs Family Flanning

Track 10:Menopause

Track 9. Menopause

Menopause is well known concept in Gynecology. The number of Research institutes working on Menopauseconcepts are about 40-50 and the number of Universities are approximately 250 which are consisting menopause topics in the department of Gynecology and the funding towards the research on this topic is in between the figures of $30000 - $50000 ,Target audience are of about 20% in the industry, Academia 40% and 40% of others. Menopause is also known as the climacteric, which is the time in most women's lives where the menstrual periods stop permanently, and she will be no longer able to have children.

2nd World Congress on Public Health and Nutrition ,March 22-24, 2017 , Rome, Italy; 2nd International Conference on Wound Care, Ostomy & Continence Nursing Practices ,June 7-8, 2017 , Milan, Italy; International Conference on Social Sciences & Interdisciplinary Studies,August 7-8, 2017 , London, UK;2nd World Congress on Health Economics Policy and Outcomes Research,June 29-30, 2017 , Madrid, Spain;4th International Conference and Exhibition on Medical Physics and Biophysics ,June 29-30, 2017 , London, UK;10th World Congress on Healthcare & Technologies,July 17-18, 2017 , Lisbon, Portugal;5th International Conference on Medical Informatics and Telemedicine,August 29-30, 2017 , Prague, Czech Republic; World Congress on Patient Safety & Quality Healthcare,September 04-05, 2017 , London, UK;2nd International Conference on Environmental Health & Global Climate Change,September 7- 8, 2017 , Paris, France;3rd International Conference on Wound Care, Tissue Repair & Regenerative Medicine,September 11-12, 2017 , Dallas, USA

Track 10-1Age at Menopause
Track 10-2Pelvic Floor Dysfunction
Track 10-3Premature Menopause
Track 10-4The Immune System in Menopause
Track 10-5Metabolic Transitions at Menopause
Track 10-6Management of Menopouse

Track 11:Infertility

Track 10. Infertility

Infertility can be described as a woman who is unable to conceive as well as being unable to carry a pregnancy to full term.Infertility is the inability of a person, plant or an animal to reproduce by natural means. It is normally not the innate state of a healthy adult organism, except in particularly among certain eusocial species (predominantly haplodiploid insects). Understanding the socio demographic factors parallel with use may assist newly married couples with family planning. As discussed in many gynecologic conferences and gynecologic meetings worldwide, the use of infertility services is not random and roughly about 50% of the women evaluated for infertility progressed to treatment, and in which only a small proportion were treated with additional advanced assisted reproductive technologies essentially Invitro fertilization.Obesity in reproductive health will centralize on two important areas which are infertility and heavy menstrual bleeding. Women who are fertile will experience a natural period of fertility before and during ovulation, and they will be naturally infertile during the latter part of the menstrual cycle. Medical and surgical management of heavy menstrual bleeding is described including the many varied issues in hysterectomy of obese woman.

2nd World Congress on Public Health and Nutrition ,March 22-24, 2017, Rome, Italy; 2nd International Conference on Wound Care, Ostomy & Continence Nursing Practices ,June 7-8, 2017 , Milan, Italy; International Conference on Social Sciences & Interdisciplinary Studies,August 7-8, 2017 , London, UK; 2nd World Congress on Health Economics Policy and Outcomes Research,June 29-30, 2017 , Madrid, Spain; 4th International Conference and Exhibition on Medical Physics and Biophysics, June 29-30, 2017 , London, UK;10th World Congress on Healthcare & Technologies,July 17-18, 2017 , Lisbon, Portugal;5th International Conference on Medical Informatics and Telemedicine,August 29-30, 2017 , Prague, Czech Republic;World Congress on Patient Safety & Quality Healthcare,September 04-05, 2017 , London, UK;2nd International Conference on Environmental Health & Global Climate Change,September 7- 8, 2017 , Paris, France;3rd International Conference on Wound Care, Tissue Repair & Regenerative Medicine,September 11-12, 2017 ,Dallas, USA.

Track 11-1Infertility Evaluation and Treatment Among Women
Track 11-2Tubal Infertility and Ectopic Pregnancy
Track 11-3Obesity & Surgical Management of Infertility
Track 11-4Artificial Gametes and Ovarian Stimulation
Track 11-5Risk of Idiopathic Male Infertility
Track 11-6Infertility Evaluation and Management

Track 12:Health-Related Behaviours In Women

Track 11: Health-Related Behaviours In Women

Behavioral Health is an extensive branch of interdisciplinary health which focuses widely on the reciprocal relationship between the characteristic view of human behaviour and well-being of the body as a whole entity. Behavioral Health is stated as the issues that can have a different outcome by changing behaviour. For example, giving up smoking can lessen the illnesses or Health Problems associated with cigarette smoking as discussed in many gynecologic conferences and gynecologic meetings worldwide. Many health conditions are caused by risk behaviours, such as, smoking, reckless driving, problem drinking, substance use , overreacting, or unprotected sexual intercourse. Fortunately, human beings have control over their conduct. Health-compromising behaviours can be eradicated by self-regulatory efforts and health enhancing behaviours that can be adopted such as preventive nutrition, physical exercise, weight control, dental hygiene, condom use or accident prevention.

3rd International Conference on Gynecology & Obstetrics October 17-19, 2017, UAE; Polycystic Ovarian Syndrome Conference November 16-18, 2017, USA; Pregnancy Summit & Child Health August 29-31, 2017, Brazil; 2nd Global Hormones Summit and Steroids June 23-25, 2017, USA; 3rd World congress on Women's Health and Breast Cancer; 18th Annual NPWH Premier Women's Healthcare Conference Oct 14-17, 2017, USA; Women's Health Conference, June 9-11, 2017, CA; Women's Healthcare Meeting and OB/GYN Nursing, November 11-14, 2017, USA; High Risk Obstetric Nursing Conference, November 11 - 14, 2017, NV; Conference on Contraceptive Technology, Nov 4-6, 2017, GA.

Track 12-1Physical Activity in Women
Track 12-2Alcohol Use and Alcohol Problems in Women
Track 12-3Eating Disorders in Women: Current Issues and Debates
Track 12-4Behavioural Changes in Women During Menopause
Track 12-5Psychology of Women During Pregnancy
Track 12-6Vaginal Cancer

Track 13:Gynecologic Surgery

Track 12. Gynecologic Surgery

Gynecologic Surgery is giving a fundamental, peer-assessed data for clinical articles managing all parts of agent and office gynecology. "Gynecological Surgery", established in 2004, is the first and head peer-surveyed logical diary devoted to all parts of research, advancement, and preparing in gynecological surgery .Gynecological surgery alludes to surgery on the female conceptive framework. It incorporates strategies for amiable conditions, malignancy, fruitlessness, and incontinence. Gynecological surgery may once in a while be performed for elective or restorative purposes .Also this field is quickly changing because of new advancements and developments in endoscopy, apply autonomy, imaging and other interventional systems. Gynecological surgery is presently envelops every surgical intercession relating to ladies' wellbeing, including urogynecology , oncology and fetal surgery.

International Conference on Reproductive Health, December 04-06, 2017, Chicago, USA; 3rd World Congress on Polycystic Ovarian Syndrome, November 09-11, 2017 San Antonio, USA; 2nd World Congress on Midwifery and Women’s Health, Aug 28-30, 2017 Philadelphia, USA; Europe Midwifery and Women’s Health 2017 October 2-4, 2017 London, UK; ; 16th Global Annual Oncologists Meeting, April 24-25, 2017, Dubai, UAE;2nd International Congress on Contemporary Issues in Women Cancers & Gynecologic Oncology, Aug 28-29, 2017, London, UK; International Conference on Cancer Genetics and Epigenetics, .October 26-28 2017, Osaka, Japan; 14th Asia Pacific Oncologists Annual Meeting, November 13-15, 2017, Melbourne, Australia; 26th World Cancer Convention, November 27-28, 2017, Dubai, UAE; International Conference on Cancer Diagnostics, November 27- 28, 2017, Dubai, UAE .

Track 13-1Tubal Ligation
Track 13-2Microsurgery
Track 13-3In Vitro Fertilization
Track 13-4Female Urology
Track 13-5Laparoscopy & Laser Surgery
Track 13-6Colposcopy & Hysteroscopy
Track 13-7Vacuum Aspiration
Track 13-8Oophorectomy
Track 13-9Salpingoophorectomy
Track 13-10Uterine Artery Embolization
Track 13-11Endometrial Biopsy

Track 14:Clinical Gynecologic Oncology

Track 13.Clinical Gynecology Oncology

Gynecology Oncology is the learn about any disease that starts in a lady's regenerative organs. The five Gynecologic tumors begins in the lady's pelvis at better places. Every tumor is one of a kind by its indications, signs, hazard components and in their systems of aversion. All these five unique sorts of Gynecology Cancers chance increments with the age. At the point when these malignancies were analyzed at their initial stages, the treatment will be more efficient. The five noteworthy sorts of tumor influence a lady's regenerative organs are ovarian, uterine, cervical, vulvar, and vaginal growth. All these as a gathering are known as Gynecologic growths.

19th World Cancer Conference, November 21-23, 2017 London, UK; 2^nd Cancer Diagnostics Conference May 8-10, 2017 Barcelona, Spain; ESMO 2017 Congress, September 8-12, 2017, Spain; Breast Cancer Conference, October 16-18, 2017 San Francisco, USA; 8th Blood Cancer Conference June 26-27, 2017 London, UK; Annual Scientific Meeting of the British Gynaecological Cancer Society, 15-16 June 2017 Glasgow, UK; Gynecologic Oncology Congress, July 20-21, 2017 Chicago, USA; 18^th World Conference on Lung Cancer October 15 - 18 2017; Preventive oncology July 20-21, 2017 Chicago, USA; 9^th Cancer Biomarkers Conference August 23-24, 2017 Birmingham, UK; 3^rd Urologic Oncology Conference June 26-28, 2017 Baltimore; 16^th Global Annual Oncologists Meeting April 24-25, 2017 Dubai, UAE; Yokohama, Japan; European Lung Cancer Conference, May 5-8,2017,Switzerland; Gastrointestinal Cancer Conference, October 16-18, 2017 Baltimore, USA.

Track 14-1Cancer in Pregnancy
Track 14-2Blood Component Therapy
Track 14-3Signal Tranduction Pathways
Track 14-4Germ Cells, Stromal and Other Ovarian Tumors

Track 15:Women Reproductive Cancers

Track 14. Women Reproductive Cancers:

Women Reproductive Cancers is the restorative pathology subspecialty managing the review and analysis of sickness including the female genital tract. A doctor who hones gynecologic pathology is a gynecologic pathologist. The term begins from the Greek gyno-(gynaikos) signifying "lady" and the postfix - ology, signifying "investigation of". Gestational trophoblastic malady (GTD) is the general name for a gathering of uncommon tumors that happen amid pregnancy in the fetalchorion, GTD can happen in any sort of pregnancy which is quite often reparable if discovered ahead of schedule in Oncology Gynecology Pathogenesis. Uterine leiomyosarcoma (LMS) is an uncommon uterine harm it is a forceful tumor connected with a high danger of repeat and passing, paying little mind to stage. Choriocarcinoma is a disease that grows most regularly from strange placenta and it is about 100% reparable if fitting chemotherapy is managed after the tumor mass is isolated from inside the uterus.

4th World Congress on Breast Cancer and Women’s Health May 08-10, 2017 Holiday Inn Atrium, Singapore;

8th International Conference on Blood and Oncology Research, .June 26-28, 2017,London, UK; 9th International Conference on Leukemia and Hematologic Oncology; October 05-06,2017,London,UK; International Conference on Hematology and Oncology, June 29-July 01, 2017, Bangkok, Thailand; International Conference on Family Nursing, June 13-15, 2016 Philadelphia, USA;15th Euronursing Conference, Oct 17-19, Rome Italy; Nursing and Healthcare Conference, Dec 5-7, Dallas, USA; 3^rd International Congress on Gynecology and Obstetrics; The New Zealand College of Midwives 14th Biennial National Conference, August 26-28, 2016, Auckland; Australian Nurses and Midwives Conference, September 8 – 9, 2016, Melbourne Convention and Exhibition Centre, 1 Convention Centre Place , South Wharf Victoria; NETNEP 2016, 6th International Nurse Education Conference, April 3-6, 2016, Brisbane, Australia, Maternidad La Luz, Midwifery Education Accreditation Council, National College of Midwifery, Nizhoni Institute of Midwifery, Birthingway College of Midwifery.

Track 15-1Ovarian Cancer
Track 15-2Diagnosis and Treatment
Track 15-3Cervical Cancer
Track 15-4Endometrial Cancer
Track 15-5Vulvar Cancer
Track 15-6Vaginal Cancer
Track 15-7Fallopian Tube Cancer
Track 15-8Breast Cancer
Track 15-9Signs & Symptoms
Track 15-10Causes and Risk Factors

Track 16:Male Reproductive Cancers

Track 15. Male Reproductive Cancers

Male Reproductive Cancers is a companion assessed restorative diary covering gynecology as it identifies with the fields of pediatrics and juvenile medication. It was set up in 1988 as Adolescent and Pediatric Gynecology, acquiring its present name in 1996. It is distributed six times each year by Elsevier, which has distributed the diary since 1988; it is likewise the official diary of the North American Society for Pediatric and Adolescent Gynecology. The supervisor in-boss is Joseph S. Sanfilippo (Magee-Womens Hospital of UPMC). As per the Journal Citation Reports, the diary has a 2014 effect element of 1.683.

International Conference on Family Nursing, June 13-15, 2016 Philadelphia, USA;15th Euro nursing Conference, Oct 17-19, Rome Italy; Nursing and Healthcare Conference, Dec 5-7, Dallas, USA; 3^rd International Congress on Gynecology and Obstetrics; 7th Global Nursing and Healthcare conference, August 18-20, 2016 Sao Paulo, Brazil; 11th International Normal Labor and Birth conference, October 10-13, 2016, Western Sydney; 3rd Commonwealth Nurses and Midwives March 12 -13, 2016, London UK; 5^th International Conference on Family Nursing, June 13-15, 2016 Philadelphia, USA; 7th Global Nursing and Healthcare Conference August 18-20, 2016 Sao Paulo, Brazil; for the 9th Council of International Neonatal Nurses Conference, August 14 - 17, Vancouver, Canada; 5th Global Congress for Consensus in Paediatrics and Child Health, March 3–6, 2016, Xi'an, China;2nd World Congress on Public Health and Nutrition March 22-24, 2017 | Rome, Italy.

Track 16-1Testicular Cancer
Track 16-2Prostate Cancer
Track 16-3Signs and Symptoms
Track 16-4Causes and Risk Factors
Track 16-5Testings, Screening, Treatment and Diagnosis
Track 16-6Penile Cancer

Track 17:Gynecologic Cancers: Case Report

Track 16. Gynecologic Cancers: Case Report

Ladies with early cervical malignancies and pre-diseases more often than not have no manifestations. Manifestations regularly don't start until a pre-tumor turns into a genuine intrusive disease and develops into adjacent tissue. At the point when this happens, the most widely recognized manifestations are: Abnormal vaginal dying, for example, seeping after sex (vaginal intercourse), seeping after menopause, draining and spotting amongst periods, and having longer or heavier (menstrual) periods than common. Seeping in the wake of douching, or after a pelvic exam is a typical side effect of cervical tumor however not pre-disease. A strange release from the vagina − the release may contain some blood and may happen between your periods or after menopause; Pain amid sex (vaginal intercourse).

Global Summit on Oncology & Cancer, May 25-27, 2017, Osaka, Japan; World Congress on Preventive Oncology, July 20-21, 2017, Chicago, USA; 16th Global Annual Oncologists Meeting, April 24-25, 2017, Dubai, UAE;2nd International Congress on Contemporary Issues in Women Cancers & Gynecologic Oncology, Aug 28-29, 2017, London, UK; International Conference on Cancer Genetics and Epigenetics, .October 26-28 2017, Osaka, Japan; 14th Asia Pacific Oncologists Annual Meeting, November 13-15, 2017, Melbourne, Australia; 26th World Cancer Convention, November 27-28, 2017, Dubai, UAE; International Conference on Cancer Diagnostics, November 27- 28, 2017, Dubai, UAE; 19^th annual advanced workshop on gynecologic laparoscopic anatomy and minimally invasive surgery including pelvic floor reconstruction ,may 2017,Kentucky.

43rd Annual Scientific Meeting in San Antonio, TX from March 26-29, 2017.( Society of Gynecologic Surgeons; ESGE 26th annual congress ,oct 2017,turkey;Global Endometriosis Summit, July 2017 ,Iceland.

Track 17-1Gynecologic Cancers Case Reports on Prevention
Track 17-2Gynecologic Cancers Case Reports on Screening
Track 17-3Gynecologic Cancers Case Reports on Diagnosis
Track 17-4Gynecologic Cancers Case Reports on Treatment

Track 18:Advances in Obstetrics and Gynecology

Track 17. Advances in Obstetrics and Gynecology

The creative methodologies in negligibly obtrusive surgery that have been presented are the da Vinci mechanical stage and single port laparoscopic surgery (SPLS). Automated surgery has many preferences, for example, 3-dimensional view, the wrist like movement of the mechanical arm and ergonomically agreeable position for the specialist. Various literary works have exhibited the possibility of automated surgery in gynecologic oncology. Be that as it may, additionally research ought to be performed to exhibit the prevalence of automated surgery thought about over routine laparoscopy. Also, cost lessening of automated surgery is expected to receive mechanical surgery into gynecologic oncology around the world.

25th World Cancer Conference, Oct 19-21, 2017, London, UK; International Congress on Epigenetics & Chromatin, November 13-15, 2017, Frankfurt, Germany;International Conference on Cancer Biology R&D and Market, .June 21 - 22, 2017, Philadelphia, USA. 2^nd Cancer Diagnostics Conference & Expo, May 8-10, 2017, Barcelona, Spain; 16^th Global Annual Oncologists Meeting, April 24-25, 2017, Dubai, UAE; 3^rd World Gynecologic Oncology Congress, July 20-21, 2017, Chicago, Illinois, USA; Global Experts meeting on Oncology Case Reports, Aug 29-31, 2017, London, UK; 27^th Annual International Prostate Cancer Update 2017 January 24-27, 2017, Avon , United States; Gynecologic Oncology Meeting Semi-Annual Meeting 2017, February 9-12, 2017,Houston,Texas.

Track 18-1Carcinoma of the Cervix
Track 18-2Ovarian Function and its Disorders
Track 18-3Medicated Intrauterine Devices
Track 18-4Biology of the Ovary
Track 18-5Human Fetal Endocrines

Track 19:Medicated Intrauterine Devices

Track 18.Medicated Intrauterine Devices

The chronicled improvement of the IUD, depicting the difficulties and triumphs, and endeavors to offer an adjusted viewpoint for family arranging today. Present day IUDs are a critical part of family arranging administrations and an astounding prophylactic decision for appropriately screened ladies, giving contraception that is sheltered, successful, durable and financially savvy. Potential research procedures for what's to come are likewise talked about.

15th World Oncologists Annual Conference, October 19-20, 2017, New York, USA; 2nd International Conference on Antimicrobial Agents and Chemotherapy, October 19-20, Atlanta, USA;9th International Conference on Biomarkers, August 07-09, 2017, Osaka, Japan; 28th International Conference on Family Nursing & Health Care, June 11-13, 2017, USA; World Congress on Community Nursing, 22-24 May, 2017, USA; 24th Global Nursing and Healthcare Conference, March 02-03, Netherland, Amsterdam 2017; "International Conference on Oncology Nursing and Cancer Care", September 19-21, 2016, USA; 2nd Global Conference of the European Society of Contraception and Reproductive Health May 04-07, 2016 Basel, Switzerland; Western Mediterranean Cruise 31 Jul- 07 Aug 2016 Barcelona, Spain.

Track 19-1Uterine Geometry and IUD Performance
Track 19-2The Effect of the IUD on the Ultrastructure of the Endometrium
Track 19-3Physiological Mechanisms of IUDs
Track 19-4Pituitary-Ovarian Function in IUD Users
Track 19-5Intrauterine Contraception with the Progestasert

Track 20:Sexual and Reproductive Health and Rights

Track 20-1SRHR and Education
Track 20-2SRHR and Economic Benefits
Track 20-3SRHR and Broader Health Agenda
Track 20-4SRHR and Gender Equality
Track 20-55SRHR and the Environment

Gynecology & Obstetrics

October 02-04, 2017
Tryp Barcelona Aeropeurto, Barcelona, Spain

Theme: Best Practice & Research in Obstetrics & Gynecology